MINETTO, PAOLA
 Distribuzione geografica
Continente #
EU - Europa 1.896
Totale 1.896
Nazione #
IT - Italia 1.896
Totale 1.896
Città #
Genova 1.002
Genoa 432
Rapallo 428
Bordighera 34
Totale 1.896
Nome #
Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas, file e268c4ca-bf91-a6b7-e053-3a05fe0adea1 765
A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia, file e268c4ca-ba16-a6b7-e053-3a05fe0adea1 242
Prompt detection of L-asparaginase inactivation is crucial to optimize treatment efficacy also in aggressive lymphomas, file e268c4ca-b787-a6b7-e053-3a05fe0adea1 162
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients, file e268c4ca-ca7c-a6b7-e053-3a05fe0adea1 136
Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma, file e268c4ca-ba0d-a6b7-e053-3a05fe0adea1 121
Harnessing NK Cells for Cancer Treatment, file e268c4cb-cd90-a6b7-e053-3a05fe0adea1 96
The new small tyrosine-kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs, file e268c4cb-4326-a6b7-e053-3a05fe0adea1 95
A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis, file e268c4ca-f531-a6b7-e053-3a05fe0adea1 89
Metabolic starvation triggered by l-asparaginase sensitizes multiple myeloma cells to proteasome inhibitors by inducing DNA damage accumulation, file e268c4c9-bdbc-a6b7-e053-3a05fe0adea1 79
Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD-driven salvage approach, file e268c4ca-eb89-a6b7-e053-3a05fe0adea1 72
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells vulnerability to DNA-damaging agents, file e268c4ca-8944-a6b7-e053-3a05fe0adea1 7
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information, file e268c4ca-235e-a6b7-e053-3a05fe0adea1 6
Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes, file e268c4cd-65e1-a6b7-e053-3a05fe0adea1 6
Chronic graft versus host disease as a weapon for treating chronic myelomonocytic leukemia, file e268c4cb-7f78-a6b7-e053-3a05fe0adea1 5
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells, file e268c4ce-349a-a6b7-e053-3a05fe0adea1 4
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells, file 90274659-2248-4db2-a2d9-8e3628c61b91 3
Intesive fludarabine-high dose cytarabine-idarubicin combination as induction therapy with risk-adapted consolidation may improve treatment efficacy in younger Acute Myeloid Leukemia (AML) patients: Rationales, evidences and future perspectives, file e268c4ca-93e7-a6b7-e053-3a05fe0adea1 2
Combined assessment of WT1 and BAALC gene expression at diagnosis may improve leukemia-free survival prediction in patients with myelodysplastic syndromes, file e268c4ca-a203-a6b7-e053-3a05fe0adea1 2
Adoptive Cell Therapy and Immune Check Points Inhibitors As a Salvage Treatment for Patient Affected By Relapsed/Refractory Hodgkin's Lymphoma, file e268c4cc-a96f-a6b7-e053-3a05fe0adea1 2
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies, file e268c4c9-acdf-a6b7-e053-3a05fe0adea1 1
Combining flow cytometry and WT1 assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia, file e268c4ca-fd4d-a6b7-e053-3a05fe0adea1 1
Totale 1.896
Categoria #
all - tutte 3.645
article - articoli 3.427
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.072


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020143 10 0 0 3 4 12 22 19 32 17 15 9
2020/2021291 8 15 14 12 9 45 20 30 27 32 29 50
2021/2022590 38 31 28 102 73 33 20 37 52 33 103 40
2022/2023525 21 38 89 40 38 77 31 27 39 41 49 35
2023/2024347 28 31 34 25 46 20 68 50 24 21 0 0
Totale 1.896